Changes in the mitochondrial antioxidant systems in neurodegenerative diseases and acute brain disorders

Joanna Ruszkiewicz1, Jan Albrecht1

  • 1Department of Neurotoxicology, Mossakowski Medical Research Centre, Polish Academy of Sciences, 02-106 Warsaw, Poland.

Insights

Mitochondrial antioxidant systems, like SOD2 and GSH, are crucial for brain health. Their altered function is implicated in neurodegenerative diseases, suggesting potential therapeutic targets.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Cell Biology

Background:

  • Oxidative and nitrosative stress (ONS) are key factors in brain disease pathogenesis.
  • Cellular antioxidants neutralize reactive oxygen and nitrogen species (ROS/RNS).
  • Major antioxidants include superoxide dismutases (SODs), glutathione (GSH), thioredoxin (Trx), and peroxiredoxin (Prx).

Purpose of the Study:

  • This review focuses on the role of mitochondrial antioxidant systems in brain health and disease.
  • It highlights the importance of mitochondrial SOD2 and GSH in cellular defense.
  • The review examines alterations in these systems in various neurological conditions.

Main Methods:

  • Review of existing literature on mitochondrial antioxidant systems.
  • Analysis of studies involving human patients and animal models of neurological diseases.
  • Examination of the impact of toxins and ischemia on brain antioxidant defenses.

Main Results:

  • Mitochondrial SOD2 and GSH are critical for antioxidant defense in the brain.
  • Dysregulation of mitochondrial antioxidant systems is observed in neurodegenerative diseases, cerebral ischemia, and toxic brain injury.
  • The precise impact (beneficial or detrimental) of these changes requires further evaluation.

Conclusions:

  • Mitochondrial antioxidant systems play a vital role in protecting the brain from oxidative and nitrosative stress.
  • Aberrant function of these systems is linked to various brain pathologies.
  • Targeting mitochondrial antioxidant systems presents a potential therapeutic strategy for brain disorders.

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
19.8K
Mitochondrial Membranes01:45

Mitochondrial Membranes

A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
18.0K
Mitochondria01:37

Mitochondria

Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
21.7K
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic...
2